Basic Efavirenz Information

• INN (International Nonproprietary Name): Efavirenz.
• Brand Names Available In Canada (English): Sustiva; Atripla.
• ATC Code: J05AG03.
• Forms & Dosages: Tablets 600 mg and 200 mg; capsules 50 mg (paediatric) and 200 mg; fixed-dose combination tablet (Atripla) 600 mg efavirenz + 200 mg emtricitabine + 300 mg tenofovir.
• Manufacturers In Canada (English): Originator/blister packaging listed as BMS Canada and Gilead Sciences; generic suppliers globally include Teva, Mylan, Sandoz, Zentiva and others (local availability varies by distributor).
• Registration Status In Canada (English): Registered/marketed globally including Canada; approved for HIV-1 treatment as part of combination antiretroviral therapy.
• OTC / Rx Classification: Prescription only (Rx).

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Where do Canadians usually find efavirenz near home?

Major chains such as Shoppers Drug Mart, Rexall and London Drugs commonly stock efavirenz in larger urban pharmacies and in locations linked to HIV clinics.

Hospital pharmacies and specialized HIV clinic dispensaries are the most reliable local sources for Sustiva or Atripla.

Stocking varies by province and by store size, so calling ahead to confirm 600 mg tablet or Atripla availability saves time.

Community health centres sometimes maintain clinic-based stocks and can help patients navigate refills and special-authority paperwork with provincial plans.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

Can you order efavirenz online in Canada?

Licensed Canadian online pharmacies will dispense efavirenz with a valid prescription that complies with provincial pharmacy regulations.

Inter-provincial shipping must follow storage guidelines (store below 30°C) and provincial dispensing rules; some chain-affiliated online services provide same-courier or tracked shipping.

Cross-border purchasing from U.S. suppliers still occurs but raises concerns about DIN verification and product integrity; Health Canada and legitimacy checks are important.

Provincial drug plans and special-authority processes affect how patients source efavirenz online and in-store, and urban specialty pharmacies usually offer the smoothest home-delivery experience.

Canadian Patient Insights & Satisfaction Levels

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Where do Canadian patients share efavirenz experiences?

Discussions appear on Reddit (r/Canada, r/HIV), HealthBoards and local clinic forums where people exchange practical advice about efavirenz and Atripla use.

These platforms are commonly used to compare tolerability, dosing tips and provincial coverage experiences.

Reported Benefits And Challenges From Canadian Patients

What do Canadians say works and what causes problems?

Many patients praise efavirenz for once-daily convenience and effective viral suppression when used as part of triple therapy.

Positive posts often note rapid viral-load control and the simplicity of a fixed-dose Atripla tablet.

Common challenges reported include CNS adverse effects such as vivid dreams, insomnia, dizziness and mood changes.

Several Canadians describe switching to integrase inhibitor regimens, for example dolutegravir-based therapy, because of better tolerability.

Supply issues at community pharmacies and varied provincial coverage are frequent administrative frustrations that affect continuity of therapy.

Short anonymized patient quote: “Started on Atripla; viral load dropped fast but the dreams were intense—my clinic switched me after two months.”

Product Overview & Brand Variants

INN And Brand Names Used In Canada

What are the product names you will see?

Efavirenz (INN: efavirenz; Latin: efavirenzum) is marketed in Canada as Sustiva (efavirenz monotherapy) and as part of the fixed-dose combination Atripla (efavirenz/emtricitabine/tenofovir).

Common dosage forms include a 600 mg tablet and 200 mg capsules for dose adjustments or paediatric use, and the Atripla single-tablet regimen with efavirenz 600 mg + emtricitabine 200 mg + tenofovir 300 mg.

Legal Classification Under Health Canada

Is efavirenz regulated and how should product pages present it?

Efavirenz is prescription-only in Canada and marketed products carry a Drug Identification Number (DIN).

Originator manufacturers include Bristol-Myers Squibb for Sustiva and Gilead for Atripla; multiple generic manufacturers supply versions internationally and may be available locally through distributors.

For clinicians and patients, include WHO DDD (0.6 g/day) and ATC code J05AG03 for clinical reference.

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

What is efavirenz approved to treat?

Health Canada–authorised indications align with global guidance: treatment of HIV-1 infection as part of combination antiretroviral therapy.

Atripla and Sustiva are indicated for adults and weight- or age-appropriate paediatric use with a standard adult dose of 600 mg once daily.

Post-exposure prophylaxis (PEP) historically included efavirenz-containing options in some protocols, typically as a 28-day combination regimen in occupational-health settings.

Product listings should show DINs and approved indications for provincial formulary and dispensing clarity.

Off-Label Patterns In Canadian Healthcare

Do Canadian clinicians use efavirenz off-label?

Off-label prescribing beyond guideline-based uses is uncommon for efavirenz in Canada.

Clinicians may tailor paediatric dosing by weight bands or use efavirenz under specialist oversight in complex cases.

Because of teratogenic risk and CNS adverse effects, many prescribers favour alternatives such as dolutegravir for women of childbearing potential and patients with psychiatric histories.

How It Works In The Body

Layman’s Explanation (Canadian Patient-Friendly Tone)

How does efavirenz stop HIV?

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that sticks to the HIV reverse transcriptase enzyme like a roadblock.

That roadblock prevents the virus from copying its genetic material and lowers the amount of virus in the blood.

When combined with two nucleoside reverse transcriptase inhibitors in triple therapy, efavirenz helps the immune system recover and keeps viral replication suppressed.

Clinical Detail From Health Canada Resources

What do clinicians need to know about metabolism and interactions?

Efavirenz binds non‑competitively to reverse transcriptase and is metabolized mainly by CYP2B6 and CYP3A4.

Genetic polymorphisms in CYP2B6 can raise plasma efavirenz levels and increase CNS side effects in some people.

Clinically important drug–drug interactions include inducers and inhibitors such as rifampin and some anticonvulsants; avoid combinations that significantly alter efavirenz exposure.

Dosage & Administration

Standard Regimens Per Canadian Guidelines

What dose will most adults take?

Standard adult dosing is 600 mg orally once daily, commonly taken at bedtime and with or after food to reduce nausea.

As part of Atripla, efavirenz is taken continuously as lifelong therapy in combination ART.

For PEP, efavirenz has been included in combination regimens for 28 days in some protocols, but local occupational-health guidelines vary.

Adjustments By Patient Type (With Canadian Clinical Notes)

How is dosing adjusted for children, elderly or liver disease?

Paediatric dosing is weight-based with children ≥35 kg often receiving 600 mg once daily; lower weight bands use 200–300 mg formulations or 50 mg capsules.

Elderly patients generally start at standard doses but require close monitoring because pharmacokinetic data are limited.

Avoid efavirenz in moderate or severe hepatic impairment and monitor liver function in mild dysfunction.

No routine renal adjustment is needed for mild-to-moderate impairment, but severe renal disease or dialysis requires specialist input.

If a dose is missed, take it as soon as remembered unless it is near the next scheduled dose; do not double doses.

Contraindications & Side Effects

Common (Health Canada-Approved List)

Who should not take efavirenz and what side effects are common?

Absolute contraindications include known hypersensitivity to efavirenz or formulation components and severe hepatic impairment.

Common adverse effects include CNS symptoms such as insomnia, vivid dreams, dizziness, impaired concentration, anxiety and depression.

Gastrointestinal effects include nausea and diarrhoea, and laboratory changes can include increased liver enzymes and lipid alterations.

Rare But Serious (With Canadian Pharmacovigilance Data)

What rare but serious risks do Canadians need to know?

Severe rash, including Stevens–Johnson syndrome, and serious hepatic injury are flagged as rare but potentially severe events.

Serious psychiatric events including psychosis and suicidal ideation have been reported; Canada Vigilance case reports reflect these international safety signals.

Avoid co-administration with contraindicated drugs such as voriconazole, ergot derivatives and St John’s Wort, and counsel women of childbearing potential about teratogenic risk.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

What are common alternatives to efavirenz in Canada?

Integrase inhibitors such as dolutegravir and bictegravir are frequently chosen for first-line therapy because of improved tolerability.

NNRTI alternatives include rilpivirine (Edurant) and etravirine (Intelence) where they fit the clinical picture.

Pros And Cons List

How do efavirenz and alternatives compare?

Efavirenz pros: once‑daily dosing, long clinical experience, availability as Atripla fixed-dose tablet.

Efavirenz cons: CNS side effects, teratogenicity concerns for women of childbearing potential, notable drug interactions and growing clinician preference for integrase inhibitors for tolerability and resistance profile.

Current Research & Trends

Major Canadian Or International Studies 2022–2025

What does recent research say about efavirenz?

Recent studies through 2022–2025 highlight robust antiviral efficacy but persistent tolerability concerns, particularly neuropsychiatric effects.

Research on CYP2B6 pharmacogenomics has strengthened the link between genetic variants and higher efavirenz plasma concentrations associated with CNS adverse events.

Canadian clinic registries report frequent switching from efavirenz to dolutegravir-based regimens with symptom improvement after change.

Clinical Implications For Canadian Practice

How should Canadian prescribers act on this evidence?

Prescribers increasingly individualize ART choices considering pregnancy planning, mental-health history and drug–drug interactions.

Efavirenz remains a reasonable option where integrase inhibitors are unsuitable or unavailable, but clinicians should document counselling, monitoring and consideration of pharmacogenomics where relevant.

Common Patient Questions In Canada

FAQ: Access, Coverage And Prescription Logistics

Do I need a prescription and will provincial plans cover efavirenz?

Yes, efavirenz is prescription-only and marketed products carry a DIN needed for coverage claims.

Provincial plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may list efavirenz under specific formularies or special-authority programs; coverage, copay and prior authorizations vary by province.

Licensed Canadian online pharmacies will dispense efavirenz with a valid prescription; confirm pharmacy licence and pharmacist contact details before ordering.

FAQ: Side Effects, Pregnancy And Switching Regimens

What if I have vivid dreams or depression while taking efavirenz?

Do not stop abruptly; contact your prescriber for assessment—many patients switch safely to dolutegravir-based regimens under medical supervision.

Is efavirenz safe in pregnancy?

There is teratogenicity concern and many clinicians prefer alternatives for women planning pregnancy; discuss contraception and family planning with your provider.

What about drug interactions?

Bring a full medication list to your pharmacist and prescriber; avoid St John’s Wort and certain benzodiazepines, voriconazole and ergot derivatives with efavirenz.

Regulatory Status

Health Canada Approval Process

How is efavirenz regulated in Canada?

Efavirenz-containing products such as Sustiva and Atripla are authorised under Health Canada’s regulatory framework, which assesses safety, efficacy and quality.

Product monographs should be consulted for full clinical details and indications.

DIN Number Relevance

Why is the DIN important?

Every marketed product carries a Drug Identification Number (DIN) used by pharmacies and insurers for dispensing, reimbursement and pharmacovigilance.

Display the DIN on product pages and prescription labels to help patients with coverage claims and to confirm legitimacy.

Encourage reporting of adverse events to Canada Vigilance and to provincial public health clinics as part of pharmacovigilance.

Visual Recommendations

Infographic Ideas For Canadian Context

What patient visuals help understanding?

Create a one-page patient infographic showing a simple NNRTI mechanism, dosing tips (600 mg once daily at bedtime, with/after food), common side effects and when to call a provider, and a provincial coverage snapshot for Ontario, BC and Quebec.

Add a ‘Do/Don’t’ pictogram for interactions such as avoiding St John’s Wort and ergot derivatives.

Product Images And Table Suggestions

Which product images and tables improve trust?

Use clear images of blister packs and bottle labels for Sustiva 600 mg tablet, 200 mg capsule and the Atripla fixed-dose blister with DIN captions.

Include a price-comparison table (brand vs generic, 30 vs 90 pack), a brief provincial coverage table and a drug-interaction quick-reference table for pharmacy handouts.

Buying & Storage Advice

In-Store Vs. Online Canadian Purchase Tips

How should Canadians buy efavirenz safely?

Purchase requires a prescription; prefer reputable sources such as Shoppers Drug Mart, Rexall, London Drugs, HIV specialty pharmacies or clinic dispensaries.

For online purchases, verify the pharmacy licence and pharmacist contact information and ensure shipments meet provincial storage requirements.

In our online pharmacy, efavirenz is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Proper Storage With Canadian Climate Considerations

How should efavirenz be stored at home and in transit?

Store efavirenz below 30°C and protect from moisture and light.

Avoid leaving tablets in a hot car during summer or in damp basement areas during humid months.

For northern or rural deliveries, confirm courier handling to avoid extreme temperature exposure and keep medications in original packaging during travel.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

What will your pharmacist tell you at counselling?

Key points: efavirenz must be used only as part of combination ART; do not stop therapy suddenly; discuss mental-health history and pregnancy intentions before starting.

Pharmacists should counsel on dose (600 mg once daily at bedtime), interactions (CYP substrates/inducers), monitoring (viral load, liver enzymes, lipids) and how to report adverse events.

Practical Checklist For Patients

What should a patient bring to the clinic or pharmacy?

• Complete medication and supplement list, including OTCs and herbal products such as St John’s Wort.
• Provincial drug-card and any special-authority paperwork needed for coverage.
• Questions about pregnancy intentions, mood history and prior drug reactions.
• Storage and travel plan for maintaining medication integrity.

Delivery Across Canada (English)

Final Practical Tips

What should patients remember when choosing efavirenz?

Confirm Rx status and DIN on the dispensed product and keep the pharmacy label for reimbursement and safety records.

Discuss mental-health history and pregnancy planning with your clinician before starting efavirenz.

Report any severe rash, psychiatric changes or signs of liver injury immediately and consider switching options under specialist care if tolerability is poor.

Use community supports and manufacturer assistance programs to help with cost where provincial coverage is limited.